Indus Capital Partners, LLC Legend Biotech Corp Transaction History

Indus Capital Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$43.42 - $57.37 $436,978 - $577,371	10,064 New	10,064 $485,000
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $3.82 Million - $5.93 Million	-123,054 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $5.06 Million - $7.01 Million	123,054 New	123,054 $5.74 Million
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $3.34 Million - $4.79 Million	-94,678 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $2.44 Million - $3.89 Million	94,678 New	94,678 $3.89 Million
Q3 2020 Nov 13, 2020	SELL	$27.5 - $39.61 $3.41 Million - $4.92 Million	-124,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$36.1 - $42.56 $4.48 Million - $5.28 Million	124,100 New	124,100 $5.28 Million

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Indus Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Indus Capital Partners, LLC with notifications on news.